Transition Bio Inc

Transition Bio Inc. is a biotechnology company based in Cambridge, Massachusetts. The company employs 35 people and generates revenue exceeding $10,000 annually. Transition Bio specializes in developing innovative technologies for analyzing biomolecular condensates. Their Condensomics platform leverages advancements in biophysics and artificial intelligence to characterize condensates with high accuracy and efficiency. Utilizing droplet microfluidic approaches and cellular platforms, Transition Bio is able to map condensate structures and their modulation at a molecular level. The company's proprietary datasets are used to develop algorithms that facilitate target discovery, target validation, and drug design. This approach allows Transition Bio to contribute to the advancement of drug discovery processes through a deeper understanding of biomolecular condensates. For more information about Transition Bio and its groundbreaking technologies, please visit their website at transitionbio.com.